Nplate
These highlights do not include all the information needed to use NPLATE safely and effectively. See full prescribing information for NPLATE. N PLATE (romiplostim) for injection , for subcutaneous use Initial U.S. Approval: 2008
c45f9a58-37c1-4f76-8e36-97d38c577037
HUMAN PRESCRIPTION DRUG LABEL
Feb 17, 2022
Amgen Inc
DUNS: 039976196
Products 3
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
romiplostim
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (6)
romiplostim
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (6)
romiplostim
Product Details
FDA regulatory identification and product classification information